Assessment of scoring systems for acute-on-chronic liver failure at predicting short-Term mortality in patients with

World Journal of Gastroenterology

Volumn 22, Issue 41, 2016, Pages 9205-9213

  Kim, Hee Yeon ^a   Kim, Chang Wook ^a   Kim, Tae Yeob ^b   Song, Do Seon ^a   Sinn, Dong Hyun ^c   Yoon, Eileen L ^d   Jung, Young Kul ^e   Suk, Ki Tae ^f   Lee, Sang Soo ^g   Lee, Chang Hyeong ^h   Kim, Tae Hun ⁱ   Kim, Jeong Han ^j   Yim, Hyung Joon ^e   Kim, Sung Eun ^f   Baik, Soon Koo ^k   Lee, Byung Seok ^l   Jang, Jae Young ^m   Kim, Young Seok ⁿ   Kim, Sang Gyune ⁿ   Yang, Jin Mo ^a   Sohn, Joo Hyun ^o   Lee, Heon Ju ^p   Park, Seung Ha ^d   Choi, Eun Hee ^k   Kim, Dong Joon ^f   more..

^a The Catholic University of Korea   (South Korea)

^b Hanyang University   (South Korea)

^c Samsung Medical Center   (South Korea)

^d Inje University College of Medicine   (South Korea)

^e Korea University   (South Korea)

^f Hallym University   (South Korea)

^g Gyeongsang National University   (South Korea)

^h Catholic University of Daegu   (South Korea)

ⁱ Ewha Womans University School of Medicine   (South Korea)

^j Konkuk University School of Medicine   (South Korea)

^k Yonsei University Wonju College of Medicine   (South Korea)

^l Chungnam National University   (South Korea)

^m Soonchunhyang University College of Medicine   (South Korea)

ⁿ Soonchunhyang University   (South Korea)

^o Hanyang University Guri Hospital   (South Korea)

^p Yeungnam University College of Medicine   (South Korea)

more..

Author keywords

Acute on chronic liver failure; Alcoholic hepatitis; Mortality; Prognosis; Scoring system

Indexed keywords

BILIRUBIN; CREATININE;

ACUTE LIVER FAILURE; ADULT; AGE; AGE BILIRUBIN INTERNATIONAL NORMALIZED RATIO AND CREATININE SCORE; ALCOHOL LIVER DISEASE; ARTICLE; CHRONIC LIVER FAILURE; CHRONIC LIVER FAILURE CONSORTIUM ORGAN FAILURE SCORE; CHRONIC LIVER FAILURE SEQUENTIAL ORGAN FAILURE ASSESSMENT; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLASGOW ALCOHOLIC HEPATITIS SCORE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; MADDREY DISCRIMINANT FUNCTION; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PREDICTION; PREDICTIVE VALUE; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SOUTH KOREA; SURVIVAL TIME; TEACHING HOSPITAL; ACUTE-ON-CHRONIC LIVER FAILURE; AREA UNDER THE CURVE; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DECISION SUPPORT SYSTEM; DISEASE COURSE; HEALTH STATUS INDICATOR; HEPATITIS, ALCOHOLIC; KAPLAN MEIER METHOD; MIDDLE AGED; MULTICENTER STUDY; ORGAN DYSFUNCTION SCORE; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR;

ACUTE-ON-CHRONIC LIVER FAILURE; ADULT; AREA UNDER CURVE; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; FEMALE; HEALTH STATUS INDICATORS; HEPATITIS, ALCOHOLIC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS;

EID: 84995480794     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i41.9205     Document Type: Article

References (30)

1. Lucey MR, Mathurin P, Morgan TR. Alcoholic hepatitis. N Engl J Med 2009; 360: 2758-2769 [PMID: 19553649 DOI:10.1056/NEJMra0805786].
2. Porter HP, Simon FR, Pope CE, Volwiler W, Fenster LF. Corticosteroid therapy in severe alcoholic hepatitis. A double-blind drug trial. N Engl J Med 1971; 284: 1350-1355 [PMID: 4930603 DOI:10.1056/NEJM197106172842404].
3. Sandahl TD, Jepsen P, Thomsen KL, Vilstrup H. Incidence and mortality of alcoholic hepatitis in Denmark 1999-2008: A nationwide population based cohort study. J Hepatol 2011; 54: 760-764 [PMID: 21126790 DOI:10.1016/j.jhep.2010.07.016].
4. O'Shea RS, Dasarathy S, McCullough AJ, Practice Guideline Committee of the American Association for the Study of Liver D, Practice Parameters Committee of the American College of G. Alcoholic liver disease. Hepatology 2010; 51: 307-328 [PMID: 20034030 DOI:10.1002/hep.23258].
5. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-137, 1426-137, [PMID: 23474284 DOI:10.1053/j.gastro.2013.02.042].
6. Maddrey WC, Boitnott JK, Bedine MS, Weber FL, Mezey E, White RI. Corticosteroid therapy of alcoholic hepatitis. Gastroenterology 1978; 75: 193-199 [PMID: 352788].
7. Carithers RL, Herlong HF, Diehl AM, Shaw EW, Combes B, Fallon HJ, Maddrey WC. Methylprednisolone therapy in patients with severe alcoholic hepatitis. A randomized multicenter trial. Ann Intern Med 1989; 110: 685-690 [PMID: 2648927].
8. Dominguez M, Rincón D, Abraldes JG, Miquel R, Colmenero J, Bellot P, García-Pagán JC, Fernández R, Moreno M, Bañares R, Arroyo V, Caballería J, Ginès P, Bataller R. A new scoring system for prognostic stratification of patients with alcoholic hepatitis. Am J Gastroenterol 2008; 103: 2747-2756 [PMID: 18721242 DOI:10.1111/j.1572-0241.2008.02104.x].
9. Forrest EH, Evans CD, Stewart S, Phillips M, Oo YH, McAvoy NC, Fisher NC, Singhal S, Brind A, Haydon G, O'Grady J, Day CP, Hayes PC, Murray LS, Morris AJ. Analysis of factors predictive of mortality in alcoholic hepatitis and derivation and validation of the Glasgow alcoholic hepatitis score. Gut 2005; 54: 1174-1179 [PMID: 16009691 DOI:10.1136/gut.2004.050781].
10. Chayanupatkul M, Liangpunsakul S. Alcoholic hepatitis: A comprehensive review of pathogenesis and treatment. World J Gastroenterol 2014; 20: 6279-6286 [PMID: 24876748 DOI:10.3748/wjg.v20.i20.6279].
11. Sheth M, Riggs M, Patel T. Utility of the Mayo End-Stage Liver Disease (MELD) score in assessing prognosis of patients with alcoholic hepatitis. BMC Gastroenterol 2002; 2: 2 [PMID: 11835693].
12. Srikureja W, Kyulo NL, Runyon BA, Hu KQ. MELD score is a better prognostic model than Child-Turcotte-Pugh score or Discriminant Function score in patients with alcoholic hepatitis. J Hepatol 2005; 42: 700-706 [PMID: 15826720 DOI:10.1016/j.jhep.2004.12.022].
13. Vaa BE, Asrani SK, Dunn W, Kamath PS, Shah VH. Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc 2011; 86: 37-42 [PMID: 21193654 DOI:10.4065/mcp.2010.0281].
14. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470 [PMID: 11172350 ]DOI:10.1053/jhep.2001.22172].
15. Jalan R, Saliba F, Pavesi M, Amoros A, Moreau R, Ginès P, Levesque E, Durand F, Angeli P, Caraceni P, Hopf C, Alessandria C, Rodriguez E, Solis-Muñoz P, Laleman W, Trebicka J, Zeuzem S, Gustot T, Mookerjee R, Elkrief L, Soriano G, Cordoba J, Morando F, Gerbes A, Agarwal B, Samuel D, Bernardi M, Arroyo V. Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. J Hepatol 2014; 61: 1038-1047 [PMID: 24950482 DOI:10.1016/j.jhep.2014.06.012].
16. Crabb DW, Bataller R, Chalasani NP, Kamath PS, Lucey M, Mathurin P, McClain C, McCullough A, Mitchell MC, Morgan TR, Nagy L, Radaeva S, Sanyal A, Shah V, Szabo G. Standard Definitions and Common Data Elements for Clinical Trials in Patients With Alcoholic Hepatitis: Recommendation From the NIAAA Alcoholic Hepatitis Consortia. Gastroenterology 2016; 150: 785-790 [PMID: 26921783 DOI:10.1053/j.gastro.2016.02.042].
17. Kim WR, Biggins SW, Kremers WK, Wiesner RH, Kamath PS, Benson JT, Edwards E, Therneau TM. Hyponatremia and mortality among patients on the liver-Transplant waiting list. N Engl J Med 2008; 359: 1018-1026 [PMID: 18768945 DOI:10.1056/NEJMoa0801209].
18. Dunn W, Jamil LH, Brown LS, Wiesner RH, Kim WR, Menon KV, Malinchoc M, Kamath PS, Shah V. MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology 2005; 41: 353-358 [PMID: 15660383 DOI:10.1002/hep.20503].
19. Youden WJ. Index for rating diagnostic tests. Cancer 1950; 3: 32-35 [PMID: 15405679].
20. Mathurin P, Mendenhall CL, Carithers RL, Ramond MJ, Maddrey WC, Garstide P, Rueff B, Naveau S, Chaput JC, Poynard T. Corticosteroids improve short-Term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH. J Hepatol 2002; 36: 480-487 [PMID: 11943418].
21. Papastergiou V, Tsochatzis EA, Pieri G, Thalassinos E, Dhar A, Bruno S, Karatapanis S, Luong TV, O'Beirne J, Patch D, Thorburn D, Burroughs AK. Nine scoring models for short-Term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther 2014; 39: 721-732 [PMID: 24612165 DOI:10.1111/apt.12654].
22. Goyal SK, Dixit VK, Jain AK, Mohapatra PK, Ghosh JK. Assessment of the Model for End-stage Liver Disease (MELD) Score in Predicting Prognosis of Patients with Alcoholic Hepatitis. J Clin Exp Hepatol 2014; 4: 19-24 [PMID: 25755531 DOI:10.1016/j.jceh.2014.02.006].
23. Mallaiyappan M, Sawalakhe NR, Sasidharan M, Shah DK, Rathi PM, Bhatia SJ. Retrospective and prospective validation of model for end-stage liver disease (MELD) score in predicting mortality in patients of alcoholic liver disease. Trop Gastroenterol 2013; 34: 252-258 [PMID: 25046888].
24. Lafferty H, Stanley AJ, Forrest EH. The management of alcoholic hepatitis: A prospective comparison of scoring systems. Aliment Pharmacol Ther 2013; 38: 603-610 [PMID: 23879668 DOI:10.1111/apt.12414].
25. Palaniyappan N, Subramanian V, Ramappa V, Ryder SD, Kaye P, Aithal GP. The utility of scoring systems in predicting early and late mortality in alcoholic hepatitis: Whose score is it anyway? Int J Hepatol 2012; 2012: 624675 [PMID: 22988517 DOI:10.1155/2012/624675].
26. Sandahl TD, Jepsen P, Ott P, Vilstrup H. Validation of prognostic scores for clinical use in patients with alcoholic hepatitis. Scand J Gastroenterol 2011; 46: 1127-1132 [PMID: 21591871 DOI:10.3109/00365521.2011.587200].
27. Kryger P, Schlichting P, Dietrichson O, Juhl E. The accuracy of the clinical diagnosis in acute hepatitis and alcoholic liver disease. Clinical versus morphological diagnosis. Scand J Gastroenterol 1983; 18: 691-696 [PMID: 6675190].
28. Mookerjee RP, Lackner C, Stauber R, Stadlbauer V, Deheragoda M, Aigelsreiter A, Jalan R. The role of liver biopsy in the diagnosis and prognosis of patients with acute deterioration of alcoholic cirrhosis. J Hepatol 2011; 55: 1103-1111 [PMID: 21376092 DOI:10.1016/j.jhep.2011.02.021].
29. Christensen E, Gluud C. Glucocorticoids are ineffective in alcoholic hepatitis: A meta-Analysis adjusting for confounding variables. Gut 1995; 37: 113-118 [PMID: 7672658].
30. Rambaldi A, Saconato HH, Christensen E, Thorlund K, Wetterslev J, Gluud C. Systematic review: glucocorticosteroids for alcoholic hepatitis-A Cochrane Hepato-Biliary Group systematic review with meta-Analyses and trial sequential analyses of randomized clinical trials. Aliment Pharmacol Ther 2008; 27: 1167-1178 [PMID: 18363896 DOI:10.1111/j.1365-2036.2008.03685.x].